NeuroOne Medical Technologies Corporation
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
8.70M
on 2026-06-30, from 4.39M on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-6 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
S-3 of 2024-08-30. Not read yet. S-3 ↗
$4.7M
JonesTrading Institutional Services, agreement of 2022-12-21. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
The 10-Q filed 2026-08-13 is not read yet.
Cash
1.2 quarters
$2.0M on 2026-06-30 ÷ $1.8M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-06-12 | Public offering | not read | not read | not read | 424B5 ↗ |
| 2025-04-04 | Public offering | 16,000,000 | $0.50 | $8.0M | 424B5 ↗ |
Also on file: a 1-for-6 reverse split, 2026-04-14 8-K ↗